{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:13:36Z","timestamp":1778948016446,"version":"3.51.4"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"vor","delay-in-days":1256,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1093\/nar\/gkt305","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T05:53:49Z","timestamp":1367301229000},"page":"6034-6044","source":"Crossref","is-referenced-by-count":225,"title":["Small molecule induced reactivation of mutant p53 in cancer cells"],"prefix":"10.1093","volume":"41","author":[{"given":"Xiangrui","family":"Liu","sequence":"first","affiliation":[]},{"given":"Rainer","family":"Wilcken","sequence":"additional","affiliation":[]},{"given":"Andreas C.","family":"Joerger","sequence":"additional","affiliation":[]},{"given":"Irina S.","family":"Chuckowree","sequence":"additional","affiliation":[]},{"given":"Jahangir","family":"Amin","sequence":"additional","affiliation":[]},{"given":"John","family":"Spencer","sequence":"additional","affiliation":[]},{"given":"Alan R.","family":"Fersht","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2013,4,27]]},"reference":[{"key":"key\n\t\t\t\t20171013132841_gkt305-B1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","article-title":"The rebel angel: mutant p53 as the driving oncogene in breast cancer","volume":"33","author":"Walerych","year":"2012","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B5","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B6","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/sj.onc.1210291","article-title":"Structure-function-rescue: the diverse nature of common p53 cancer mutants","volume":"26","author":"Joerger","year":"2007","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B8","doi-asserted-by":"crossref","first-page":"a000919","DOI":"10.1101\/cshperspect.a000919","article-title":"The tumor suppressor p53: from structures to drug discovery","volume":"2","author":"Joerger","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B9","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1073\/pnas.94.26.14338","article-title":"Thermodynamic stability of wild-type and mutant p53 core domain","volume":"94","author":"Bullock","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B11","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural basis for understanding oncogenic p53 mutations and designing rescue drugs","volume":"103","author":"Joerger","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B12","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1073\/pnas.0805326105","article-title":"Targeted rescue of a destabilized mutant of p53 by an in silico screened drug","volume":"105","author":"Boeckler","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B13","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1021\/ja301056a","article-title":"Halogen-enriched fragment libraries as leads for drug rescue of mutant p53","volume":"134","author":"Wilcken","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc2763","article-title":"Awakening guardian angels: drugging the p53 pathway","volume":"9","author":"Brown","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B15","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.286.5449.2507","article-title":"Pharmacological rescue of mutant p53 conformation and function","volume":"286","author":"Foster","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B16","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/sj.onc.1205362","article-title":"Characterization of the p53-rescue drug CP-31398 in vitro and in living cells","volume":"21","author":"Rippin","year":"2002","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tox.2011.08.009","article-title":"Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs","volume":"289","author":"Johnson","year":"2011","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B18","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.tetlet.2012.05.025","article-title":"Synthesis of a 1,3,5-benzotriazepine-2,4-dione based library","volume":"53","author":"Chuckowree","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/co100011g","article-title":"Microwave-mediated synthesis of an arylboronate library","volume":"13","author":"Spencer","year":"2011","journal-title":"ACS Comb. Sci."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B20","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.tetlet.2011.05.025","article-title":"Synthesis of a (piperazin-1-ylmethyl)biaryl library via microwave-mediated Suzuki-Miyaura cross-couplings","volume":"52","author":"Spencer","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.tetlet.2012.01.081","article-title":"Microwave-mediated synthesis and manipulation of a 2-substituted-5-aminooxazole-4-carbonitrile library","volume":"53","author":"Spencer","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B22","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.tetlet.2011.07.147","article-title":"Synthesis and solid state study of pyridine- and pyrimidine-based fragment libraries","volume":"52","author":"Spencer","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.bmc.2011.01.010","article-title":"Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity","volume":"19","author":"Spencer","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B24"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B26","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1107\/S090744499900846X","article-title":"Integration of macromolecular diffraction data","volume":"55","author":"Leslie","year":"1999","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B27","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ijc.26127","article-title":"CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol","volume":"130","author":"Liu","year":"2012","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/j.1460-2075.1990.tb08279.x","article-title":"Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form","volume":"9","author":"Gannon","year":"1990","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B31","first-page":"3689","article-title":"Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein","volume":"9","author":"Legros","year":"1994","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/bjc.1990.123","article-title":"Evidence for allosteric variants of wild-type p53, a tumour suppressor protein","volume":"61","author":"Cook","year":"1990","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B33","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1016\/j.bmcl.2010.12.038","article-title":"Non-oxime pyrazole based inhibitors of B-Raf kinase","volume":"21","author":"Newhouse","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B34","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.1211550109","article-title":"Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition","volume":"109","author":"Wilcken","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B35","doi-asserted-by":"crossref","first-page":"13590","DOI":"10.1073\/pnas.1211557109","article-title":"First-order rate-determining aggregation mechanism of p53 and its implications","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ccr.2012.03.042","article-title":"Allele-specific p53 mutant reactivation","volume":"21","author":"Yu","year":"2012","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/carcin\/bgl132","article-title":"Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers","volume":"28","author":"Dearth","year":"2007","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B38","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.onc.1202041","article-title":"Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay","volume":"16","author":"Di Como","year":"1998","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B39","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B41","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood-2005-02-0553","article-title":"MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy","volume":"106","author":"Kojima","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B42","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jnci\/djp355","article-title":"Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53","volume":"101","author":"Van Maerken","year":"2009","journal-title":"J. Natl Cancer Inst."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1349-7006.2010.01821.x","article-title":"Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells","volume":"102","author":"Endo","year":"2011","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B45","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B48","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/pro.507","article-title":"Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding","volume":"19","author":"Kaar","year":"2010","journal-title":"Protein Sci."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","article-title":"Transcription-independent p53 apoptosis: an alternative route to death","volume":"20","author":"Speidel","year":"2010","journal-title":"Trends Cell Biol."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B50","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B51","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1083\/jcb.139.5.1281","article-title":"Movement of Bax from the cytosol to mitochondria during apoptosis","volume":"139","author":"Wolter","year":"1997","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20171013132841_gkt305-B52","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013132841_gkt305-B53","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/blood-2005-12-5148","article-title":"Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia","volume":"108","author":"Kojima","year":"2006","journal-title":"Blood"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/41\/12\/6034\/16801437\/gkt305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:52:00Z","timestamp":1595721120000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/41\/12\/6034\/1027715\/Small-molecule-induced-reactivation-of-mutant-p53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,27]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,4,27]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkt305","relation":{},"ISSN":["1362-4962","0305-1048"],"issn-type":[{"value":"1362-4962","type":"electronic"},{"value":"0305-1048","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,7,8]]},"published":{"date-parts":[[2013,4,27]]}}}